AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33670285 — intervention group
Group type: COMPARATOR
Intervention: No GMO labels
Number of subjects: 434
Study 36435795 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately restricted carbohydrate (MRC) diet (42–45% carbohydrate, 35–40% fats)
Number of subjects: 70
Study 36435795 — intervention group
Group type: COMPARATOR
Intervention: Normal weight loss (NWL) diet (52–55% carbohydrate, 25–30% fats)
Number of subjects: 70
Study 32325534 — intervention group
Group type: EXPERIMENTAL
Intervention: Delegation of home visits to health care assistants
Number of subjects: 274
Study 32325534 — intervention group
Group type: COMPARATOR
Intervention: Home visits conducted by health care assistants
Number of subjects: 274
Study 32325534 — intervention group
Group type: COMPARATOR
Intervention: Self-employment vs. being employed
Number of subjects: 274
Study 32325534 — intervention group
Group type: COMPARATOR
Intervention: Single vs. shared practice
Number of subjects: 274
Study 32325534 — intervention group
Group type: COMPARATOR
Intervention: Patient numbers per 3 months
Number of subjects: 274
Study 32325534 — intervention group
Group type: COMPARATOR
Intervention: Health care assistants' qualifications
Number of subjects: 274
Study 32325534 — intervention group
Group type: COMPARATOR
Intervention: Further training for home visits
Number of subjects: 274
Study 33270064 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading
Number of subjects: 202
Study 33270064 — intervention group
Group type: COMPARATOR
Intervention: Delayed loading
Number of subjects: 202
Study 33975010 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual combination therapy, specifically carbapenem-polymyxin regimen
Number of subjects: 1012
Study 33975010 — intervention group
Group type: COMPARATOR
Intervention: Local guidelines for treating CR-GNB
Number of subjects: 1012
Study 33975010 — intervention group
Group type: COMPARATOR
Intervention: Access to Infectious Diseases consultation
Number of subjects: 1012
Study 33853792 — intervention group
Group type: EXPERIMENTAL
Intervention: iDBT-Pain skills training intervention (6 sessions of 60-90 minutes each, delivered via Zoom)
Number of subjects: 3
Study 36360723 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated nocturnal train noise (30 events per night, 52 dB(A))
Number of subjects: 70
Study 36360723 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated nocturnal train noise (60 events per night, 54 dB(A))
Number of subjects: 70
Study 36360723 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C intake after noise exposure
Number of subjects: 70
Study 36360723 — intervention group
Group type: COMPARATOR
Intervention: Control pattern (regular background noise)
Number of subjects: 70
Study 33087159 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP5094 10 mg/kg every 4 weeks for a total of three administrations, alongside concomitant MTX.
Number of subjects: 66
Study 33087159 — intervention group
Group type: COMPARATOR
Intervention: Placebo every 4 weeks for a total of three administrations, alongside concomitant MTX.
Number of subjects: 66
Study 35189544 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar drain (LD) insertion at the time of surgery
Number of subjects: 38
Study 35189544 — intervention group
Group type: COMPARATOR
Intervention: No lumbar drain (no LD) placement
Number of subjects: 38
Study 35189544 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar drain (LD) insertion
Number of subjects: 38
Study 34492522 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 mg once daily
Number of subjects: 278
Study 34492522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study 36018418 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified vacuum‐formed retainers (mVFRs)
Number of subjects: 35
Study 36018418 — intervention group
Group type: COMPARATOR
Intervention: Hawley retainers (HRs)
Number of subjects: 35
Study 36421044 — intervention group
Group type: EXPERIMENTAL
Intervention: A-PRF
Number of subjects: 17
Study 36421044 — intervention group
Group type: COMPARATOR
Intervention: SCTG
Number of subjects: 17
Study 34109594 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Sanprobi Barrier (2.5 × 10^9 CFU)
Number of subjects: 48
Study 34109594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 32857481 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogen (oCEE)
Number of subjects: 109
Study 32857481 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17β‐estradiol (tE2)
Number of subjects: 109
Study 32857481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 35251499 — intervention group
Group type: EXPERIMENTAL
Intervention: Two 4.5 mm cannulated screws (CCS group)
Number of subjects: 60
Study 35251499 — intervention group
Group type: COMPARATOR
Intervention: Kirschner wire (K wire group)
Number of subjects: 60
Study 33213529 — intervention group
Group type: EXPERIMENTAL
Intervention: Zilucoplan (32.4 mg subcutaneously daily) plus IV ceftriaxone (2g daily for 14 days) and standard of care
Number of subjects: 81
Study 33213529 — intervention group
Group type: COMPARATOR
Intervention: Standard of care plus IV ceftriaxone (2g daily for 1 week)
Number of subjects: 81
Study 34233983 — intervention group
Group type: EXPERIMENTAL
Intervention: CCENT model (coached, coordinated, enhanced neonatal transition)
Number of subjects: 236
Study 32404287 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic treadmill training for 12 weeks
Number of subjects: 22
Study 32404287 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 22
Study 35829971 — intervention group
Group type: EXPERIMENTAL
Intervention: MyChoices app
Number of subjects: 60
Study 34511184 — intervention group
Group type: EXPERIMENTAL
Intervention: Vadadustat 150 mg with sodium ferrous citrate
Number of subjects: 0
Study 34511184 — intervention group
Group type: EXPERIMENTAL
Intervention: Vadadustat 150 mg with ferric citrate hydrate
Number of subjects: 0
Study 34511184 — intervention group
Group type: EXPERIMENTAL
Intervention: Vadadustat 150 mg with sucroferric oxyhydroxide
Number of subjects: 0
Study 34511184 — intervention group
Group type: EXPERIMENTAL
Intervention: Vadadustat 150 mg with ferrous sulfate
Number of subjects: 0
Study 34511184 — intervention group
Group type: COMPARATOR
Intervention: Vadadustat 150 mg without iron-containing agents
Number of subjects: 0
Study 35034664 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG-driven robot-assisted therapy
Number of subjects: 24
Study 35034664 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented training
Number of subjects: 24
Study 34125699 — intervention group
Group type: EXPERIMENTAL
Intervention: PBO-LLINs
Number of subjects: 1010
Study 34125699 — intervention group
Group type: COMPARATOR
Intervention: Standard LLINs
Number of subjects: 1010
Study 36231735 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Strengthening Intervention for Refugees (FSI-R)
Number of subjects: 80
Study 33882893 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring of adherence to inhalation therapies, weekly home spirometry, video-conferencing, self-management app, professional telephone coaching.
Number of subjects: 402
Study 33882893 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care arm (control group).
Number of subjects: 402
Study 32567356 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsychosocial intervention delivered in six structured two-hour sessions
Number of subjects: 41
Study 32567356 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 41
Study 33863342 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised supported self‐management approach for physical activity (LEAP-MS)
Number of subjects: 0
Study 35912671 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased availability of lower energy options (70%)
Number of subjects: 77
Study 35912671 — intervention group
Group type: COMPARATOR
Intervention: Standard availability of lower energy options (30%)
Number of subjects: 77
Study 33025024 — intervention group
Group type: EXPERIMENTAL
Intervention: Diesel exhaust exposure
Number of subjects: 38375
Study 33025024 — intervention group
Group type: EXPERIMENTAL
Intervention: Polycyclic aromatic hydrocarbons (PAH) exposure
Number of subjects: 38375
Study 33025024 — intervention group
Group type: COMPARATOR
Intervention: Control group (breast cancer-free women)
Number of subjects: 38375
Study 32255266 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid (triamcinolone acetonide, 60 mg)
Number of subjects: 50
Study 32255266 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucocyte-rich platelet-rich plasma (LR-PRP)
Number of subjects: 50
Study 32281430 — intervention group
Group type: EXPERIMENTAL
Intervention: One stacked pulsed dye laser (PDL) technique
Number of subjects: 22
Study 32281430 — intervention group
Group type: EXPERIMENTAL
Intervention: Stacked pulsed dye laser (PDL) in two sessions, 1 month apart
Number of subjects: 22
Study 36202557 — intervention group
Group type: EXPERIMENTAL
Intervention: MitraClip implantation plus guideline‐directed medical therapy (GDMT)
Number of subjects: 614
Study 36202557 — intervention group
Group type: COMPARATOR
Intervention: GDMT alone
Number of subjects: 614
Study 33386332 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-dose regimen (0, 6)
Number of subjects: 1207
Study 33386332 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-dose regimen (0, 12)
Number of subjects: 1207
Study 33386332 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-dose regimen (0, 2, 6)
Number of subjects: 1207
Study 34201450 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Group and Enhanced Group received 20 smoking-related messages over 2 weeks; Enhanced Group received an extra 6 oral health-related messages for one week.
Number of subjects: 403
Study 34201450 — intervention group
Group type: COMPARATOR
Intervention: WeChat-based smoking cessation intervention
Number of subjects: 403
Study 33859297 — intervention group
Group type: COMPARATOR
Intervention: Transcranial static magnetic stimulation (tSMS) over the left primary motor cortex for 20 min
Number of subjects: 12
Study 33859297 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study 32807102 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinded safety data analysis
Number of subjects: 53
Study 32807102 — intervention group
Group type: EXPERIMENTAL
Intervention: Unblinded safety data analysis
Number of subjects: 53
Study 36414975 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone 250 mg infusion (1 × 250 mg over 5 min)
Number of subjects: 120
Study 36414975 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4 mL isotonic saline NaCl 0.9%)
Number of subjects: 120
Study 33293396 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (4000 IU per day)
Number of subjects: 860
Study 33293396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 860
Study 35913755 — intervention group
Group type: EXPERIMENTAL
Intervention: General exercise intervention (≥2.5 hours of intense physical activity/week)
Number of subjects: 151
Study 35913755 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued exercise as usual)
Number of subjects: 151
Study 33774890 — intervention group
Group type: EXPERIMENTAL
Intervention: Male suffering PWL
Number of subjects: 785
Study 33774890 — intervention group
Group type: COMPARATOR
Intervention: Health information PWL
Number of subjects: 785
Study 32350555 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in interdisciplinary tumor boards at university hospitals
Number of subjects: 54
Study 32350555 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in interdisciplinary tumor boards at level 3 hospitals
Number of subjects: 54
Study 33016374 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine (placebo-adjusted effect on ADAS-Cog at week 24)
Number of subjects: 1047
Study 33016374 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine (capsules)
Number of subjects: 1047
Study 33016374 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine (patch)
Number of subjects: 1047
Study 33016374 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1047
Study 33016374 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 1047
Study 35051316 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional dentifrice (Colgate Maximum Anticaries Protection)
Number of subjects: 105
Study 35051316 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrice containing 2% hydrogen peroxide (Colgate Luminous White Advanced)
Number of subjects: 105
Study 35051316 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrice containing sodium tripolyphosphate (Sensodyne True White)
Number of subjects: 105
Study 35051316 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrice containing activated charcoal (Black is White)
Number of subjects: 105
Study 35051316 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrice containing blue covarine (Close Up White Now)
Number of subjects: 105
Study 35051316 — intervention group
Group type: COMPARATOR
Intervention: Control (brushing with only water)
Number of subjects: 105
Study 35051316 — intervention group
Group type: EXPERIMENTAL
Intervention: All whitening dentifrices
Number of subjects: 105
Study 35717820 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI-based therapy (monotherapy or combination)
Number of subjects: 1145
Study 35717820 — intervention group
Group type: COMPARATOR
Intervention: VEGF inhibitor monotherapy
Number of subjects: 1145
Study 35717820 — intervention group
Group type: COMPARATOR
Intervention: mTOR inhibitor monotherapy
Number of subjects: 1145
Study 33632904 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flow anesthesia
Number of subjects: 44
Study 33632904 — intervention group
Group type: COMPARATOR
Intervention: High-flow anesthesia
Number of subjects: 44
Study 34232300 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Connects (FC) program with 1 to 3 nurse home visits starting at 3 weeks of age.
Number of subjects: 549
Study 34232300 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment as usual).
Number of subjects: 549
Study 33883772 — intervention group
Group type: EXPERIMENTAL
Intervention: Living environment factors (safe drinking water, sanitation, hygiene, etc.)
Number of subjects: 224
Study 33883772 — intervention group
Group type: EXPERIMENTAL
Intervention: Family characteristics (parental education, occupation, income)
Number of subjects: 224
Study 33883772 — intervention group
Group type: EXPERIMENTAL
Intervention: Availability of safe drinking water and sanitation, use of mosquito nets
Number of subjects: 224
Study 34738161 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus group (0.5 mg penehyclidine injected before anesthesia)
Number of subjects: 354
Study 34738161 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion group (0.25 mg penehyclidine injected before anesthesia and another 0.25 mg infused after surgery)
Number of subjects: 354
Study 34738161 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo normal saline injected before anesthesia and infused over 48 hours after surgery)
Number of subjects: 354
Study 34738161 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus group
Number of subjects: 354
Study 34738161 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion group
Number of subjects: 354
Study 33086290 — intervention group
Group type: COMPARATOR
Intervention: Pred+NSAID-Pre (control group)
Number of subjects: 456
Study 33086290 — intervention group
Group type: EXPERIMENTAL
Intervention: Pred+NSAID-Post
Number of subjects: 456
Study 33086290 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID-Pre
Number of subjects: 456
Study 33086290 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID-Post
Number of subjects: 456
Study 33086290 — intervention group
Group type: EXPERIMENTAL
Intervention: Dropless group (sub-Tenon depot of dexamethasone)
Number of subjects: 456
Study 33086290 — intervention group
Group type: EXPERIMENTAL
Intervention: Pred+NSAID-Pre and Pred+NSAID-Post groups
Number of subjects: 456
Study 33086290 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID monotherapy and dropless groups
Number of subjects: 456
Study 33086290 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 456
Study 32269028 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week free nicotine replacement therapy (NRT) sample (either patch or gum) plus brief medication advice and cessation service referral.
Number of subjects: 825
Study 32269028 — intervention group
Group type: COMPARATOR
Intervention: Brief smoking cessation advice and service referral (control group).
Number of subjects: 825
Study 35201290 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal-sparing intensity-modulated RT (ES-IMRT)
Number of subjects: 90
Study 35201290 — intervention group
Group type: COMPARATOR
Intervention: Standard RT (control arm)
Number of subjects: 90
Study 32811681 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential radiation followed by chemotherapy (RT‐CT)
Number of subjects: 17070
Study 32811681 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiation (CCRT)
Number of subjects: 17070
Study 32811681 — intervention group
Group type: COMPARATOR
Intervention: Sequential chemotherapy followed by radiation (CT‐RT)
Number of subjects: 17070
Study 34499248 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact Lens Dynamometry (CLD)
Number of subjects: 36
Study 34499248 — intervention group
Group type: COMPARATOR
Intervention: IOPstim
Number of subjects: 36
Study 33789270 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochlear Implantation (CI)
Number of subjects: 155
Study 33789270 — intervention group
Group type: COMPARATOR
Intervention: CROS hearing aids
Number of subjects: 155
Study 33789270 — intervention group
Group type: COMPARATOR
Intervention: Bone-Anchored Hearing Systems (BAHS)
Number of subjects: 155
Study 33789270 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 155
Study 35077956 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence-contingent wage supplements
Number of subjects: 91
Study 35077956 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 91
Study 33719913 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive text flyer
Number of subjects: 1070
Study 33719913 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive graphics flyer
Number of subjects: 1070
Study 33719913 — intervention group
Group type: COMPARATOR
Intervention: Neutral text flyer
Number of subjects: 1070
Study 32654156 — intervention group
Group type: EXPERIMENTAL
Intervention: Inotersen, weekly subcutaneous administration for 65 weeks
Number of subjects: 0
Study 32654156 — intervention group
Group type: COMPARATOR
Intervention: Placebo, weekly subcutaneous administration for 65 weeks
Number of subjects: 0
Study 32654156 — intervention group
Group type: EXPERIMENTAL
Intervention: Inotersen
Number of subjects: 0
Study 35142000 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex Oral Semantic Fluency (COSEF) task
Number of subjects: 17
Study 35142000 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonemic and two types of semantic COWATs
Number of subjects: 17
Study 35142000 — intervention group
Group type: EXPERIMENTAL
Intervention: COSEF task
Number of subjects: 17
Study 35142000 — intervention group
Group type: COMPARATOR
Intervention: COWATs
Number of subjects: 17
Study 34305642 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal Oxygen Therapy (NOT) at 3 L/min
Number of subjects: 23
Study 34305642 — intervention group
Group type: COMPARATOR
Intervention: Placebo (ambient air 3 L/min)
Number of subjects: 23
Study 35621054 — intervention group
Group type: EXPERIMENTAL
Intervention: Passiflora setacea juice (50 g, 150 g)
Number of subjects: 24
Study 35621054 — intervention group
Group type: EXPERIMENTAL
Intervention: Passiflora setacea juice (50 g)
Number of subjects: 24
Study 35621054 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenolic metabolites from Passiflora setacea
Number of subjects: 24
Study 35621054 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PB)
Number of subjects: 24
Study 32193264 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 months RET and 800 IU/d vitamin D3
Number of subjects: 127
Study 32193264 — intervention group
Group type: COMPARATOR
Intervention: 6 months RET and placebo
Number of subjects: 127
Study 35649057 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine Group (n=48)
Number of subjects: 98
Study 35649057 — intervention group
Group type: COMPARATOR
Intervention: Face-to-Face Group
Number of subjects: 98
Study 35649057 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine Group
Number of subjects: 98
Study 34395624 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 μg/kg dose of nitroglycerin
Number of subjects: 78
Study 34395624 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 μg/kg dose of nitroglycerin
Number of subjects: 78
Study 34395624 — intervention group
Group type: COMPARATOR
Intervention: Normal saline or placebo (control group)
Number of subjects: 78
Study 32925119 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-based motor rehabilitation (experimental group)
Number of subjects: 30
Study 32925119 — intervention group
Group type: COMPARATOR
Intervention: Conventional neurorehabilitation (control group)
Number of subjects: 30
Study 35370050 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonabsorbable sutures
Number of subjects: 124
Study 35370050 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable sutures
Number of subjects: 124
Study 35370050 — intervention group
Group type: EXPERIMENTAL
Intervention: Metallic staples
Number of subjects: 124
Study 35370050 — intervention group
Group type: COMPARATOR
Intervention: All groups (nonabsorbable sutures, absorbable sutures, metallic staples)
Number of subjects: 124
Study 33662334 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of anti-IL-21 and liraglutide
Number of subjects: 308
Study 33662334 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-IL-21 alone
Number of subjects: 308
Study 33662334 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide alone
Number of subjects: 308
Study 33662334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308
Study 33662334 — intervention group
Group type: EXPERIMENTAL
Intervention: All active treatments (anti-IL-21 + liraglutide, anti-IL-21, liraglutide)
Number of subjects: 308
Study 33662334 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 308